Jiaqi Li
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Modulating excited state via diversified electron-donating units in MR-TADF emitters: a theoretical exploration of structure-property relationships.
Journal: Physical chemistry chemical physics : PCCP
Published: December 22, 2025
Sequential CD19/CD22 CAR-T cell therapy following ASCT shows improved efficacy versus CAR-T alone in relapsed/refractory large B-cell lymphoma.
Journal: Bone marrow transplantation
Published: July 26, 2025
Perioperative symptoms in patients with thyroid cancer: a cross-sectional and longitudinal network analysis.
Journal: BMC endocrine disorders
Published: June 08, 2025
Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients.
Journal: Hematological oncology
Published: November 04, 2024
Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases.
Journal: Oncology letters
Published: August 09, 2024
A novel costimulatory molecule gene-modified leukemia cell-derived exosome enhances the anti-leukemia efficacy of DC vaccine in mouse models.
Journal: Vaccine
Published: December 18, 2023
Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models.
Journal: Frontiers in immunology
Published: August 29, 2023
Tislelizumab augment the efficacy of CD19/22 dual-targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B-cell non-Hodgkin lymphoma.
Journal: Hematological oncology
Published: July 04, 2023
Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement.
Journal: Frontiers in immunology
Published: May 08, 2023
A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4+ T cell vaccine efficiently enhances anti-leukemia immunity.
Journal: Frontiers in immunology
Published: September 13, 2022
Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma.
Journal: Frontiers in immunology
Published: July 19, 2022
Last Updated: 09/26/2026